« Back
Home /
Tigecycline

Tigecycline

Manufacturer	Adooq
Category	Oncology Neuroscience Neural Lineage Markers By Cell Type Blastoma Carcinoma Cell Biology Cell Status Proliferation Inhibitors & Compound Libraries Small Molecules By Organ Bladder Cancer
Type	Inhibitors
Specific against	other
Amount	25mg
Item no.	A10933-25
Targets	PCNA
eClass 6.1	30220300
eClass 9.0	32160605
Available
Short Description	Tigecycline is bacteriostatic and is a protein synthesis inhibitor by binding to the 30S ribosomal subunit of bacteria and thereby blocking entry of Aminoacyl-tRNA into the A site of the ribosome during prokaryotic translation.
Cas No	220620-09-7
Synonyms	Tygacil, GAR-936, WAY-GAR-936, TBG-MINO
Formula	C29H39N5O8
Solubilty	DMSO
Purity	>98%
Chemical Name	N-[(5aR, 6aS, 7S, 9Z, 10aS)-9-[amino(hydroxy)methylidene]-4, 7-bis(dimethylamino)-1, 10a, 12-trihydroxy-8, 10, 11-trioxo-5, 5a, 6, 6a, 7, 8, 9, 10, 10a, 11-decahydrotetracen-2-yl]-2-(tert-butylamino)acetamide
M. Wt.	585, 7
SMILES	CC(C)(C)NCC(=O)NC1=C(C2=C(C[C@ H]3C[C@ H]4[C@ @ H](C(=O)C(=C([C@ ]4(C(=O)C3=C2O)O)O)C(=O)N)N(C)C)C(=C1)N(C)C)O
Storage	2 years at -20C

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 25mg

available

Delivery expected until 5/30/2024